A US-based national surveillance study for the susceptibility and epidemiology of <i>Clostridioides difficile</i> isolates with special reference to ridinilazole: 2020–2021David R. Snydman, Esther Duperchy, Audrey N. Schuetz et al.|Antimicrobial Agents and Chemotherapy|2023Cited by 15
1669. A US Based National Surveillance Study for the Susceptibility and Epidemiology of <i>Clostridioides difficile</i> Associated Diarrheal Isolates with Special Reference to Ridinilazole: 2020-2021L. A. McDermott, Dimitrios I. Bourdas, Cheleste M. Thorpe et al.|Open Forum Infectious Diseases|2022Cited by 3